drugset / Trial / NCT00406315
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate change in weight as a result of switching from quetiapine to ziprasidone, in subjects with schizophrenia or schizoaffective disorder who have failed to achieve a satisfactory clinical response to quetiapine due to lack of efficacy or poor tolerability.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-12
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ziprasidone | Small molecule | 40 mg | — |
| Subject | Ziprasidone | Small molecule | 60 mg | — |
| Subject | Ziprasidone | Small molecule | 80 mg | — |